# SCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates

> **NCT07474558** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Jules Bordet Institute** · enrollment: 102 (estimated)

## Conditions studied

- Advanced or Metastatic Solid Tumour
- Antibody-Drug Conjugate
- Alopecia

## Interventions

- **DEVICE:** scalp cooling
- **OTHER:** photographs via the Belle.AI app
- **DRUG:** Antibody-Drug Conjugates

## Key facts

- **NCT ID:** NCT07474558
- **Lead sponsor:** Jules Bordet Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2030-01
- **Final completion:** 2031-09
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2026-03-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07474558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07474558, "SCALp Cooling for pReventing aLopecia With nEw anTibody-drug Conjugates". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07474558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*